Tom Malinowski bought Profound Medical Corp (NASDAQ: PROF)
Tom Malinowski bought PROF · disclosed August 26, 2021
Tom Malinowski, a NJ House member representing District 7, purchased $1,001 - $15,000 of Profound Medical Corp (PROF) on January 27, 2020. Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade. Shares of PROF have fallen 35.4% since the first observed purchase on December 20, 2019. The filing was publicly disclosed on August 26, 2021; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Tom Malinowski's complete filing history, visit Tom Malinowski's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on PROF break down as 0 strong buy, 1 buy, 0 neutral, 0 sell, 0 strong sell.
- PROF carries a Risk Score of 73 as of November 20, 2026. On this scale, a higher score means a lower risk surface.
- Tom Malinowski bought PROF in the amount range of $1,001 - $15,000 on January 27, 2020, filed under the STOCK Act.
- The filing lists Self as the transaction owner and was disclosed n/a after the trade.
- The asset description in the filing reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New.'
- Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade.
- Shares of PROF have fallen 35.4% since the first observed purchase on December 20, 2019.
- PROF carried a Q Score of 0 in its equity peer group as of date unavailable.
- PROF carried a Squeeze Score of 38 as of November 22, 2026.
Did Tom Malinowski buy or sell PROF?
The Periodic Transaction Report covers a single purchase involving PROF on January 27, 2020. The filed amount range is $1,001 - $15,000. The asset description reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New', as submitted by the filer. The report was submitted on August 26, 2021. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Tom Malinowski (House) | Buy | PROF | $1,001 - $15,000 | January 27, 2020 | August 26, 2021 |
What other PROF trades has Tom Malinowski disclosed in the past 12 months?
Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| January 14, 2020 | Buy | Self | $1,001 - $15,000 | Filing unavailable |
| December 20, 2019 | Buy | Self | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a purchase involving PROF by Tom Malinowski in the amount range of $1,001 - $15,000, with Self listed as the owner. It does not establish Tom Malinowski's total holdings in PROF, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Tom Malinowski's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded PROF?
Quantellect's current database lists these recent PROF disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has Tom Malinowski's disclosed trading performed?
A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All Tom Malinowski PROF trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Tom Malinowski buy or sell PROF?
According to the disclosure, Tom Malinowski purchased PROF on January 27, 2020.
What amount was reported for the PROF transaction?
The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated January 27, 2020, and it was disclosed on August 26, 2021.
Where can I see Tom Malinowski's other congressional trades?
Quantellect lists Tom Malinowski's complete disclosed trade history on the member profile. Tom Malinowski's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.

